[Recombinant allergens for specific immunotherapy].
Recombinant allergens for allergen specific immunotherapy are accepted in clinical practice. Some allergen variants and epitops have been presented as safety and effective methods influenced the pathomechanism of allergic process. Actual experience with recombinant allergens suggests us a new way in immunotherapy.
Kowalski
Marek L
ML
Katedra i Zakład Immunologii Klinicznej Uniwersytetu Medycznego w Łodzi.
Balwierz
Anna
A
D018076:DNA, Complementary / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D008285:Major Histocompatibility Complex / Q000276:immunology; D019444:Vaccines, DNA / Q000627:therapeutic use*
D018076:DNA, Complementary; D019444:Vaccines, DNA